# Ultramicrosize Griseofulvin

NDC: 23155-863
Generic name: Griseofulvin
Labeler / Manufacturer: Heritage Pharmaceuticals Inc d/b/a Avet Pharmaceuticals Inc
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: TABLET
Routes: ORAL
Marketing started: 20230630

FDA application: ANDA061996

## Active ingredients

- GRISEOFULVIN: 125 mg/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"23155-863"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=23155-863
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=ae369582-2e4c-48a4-ac42-0a77466654fd